# The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy

> **NCT04169464** · PHASE4 · UNKNOWN · sponsor: **MTI University** · enrollment: 200 (estimated)

## Conditions studied

- Egyptian Patients, HCV Treatment, Kidney Function

## Interventions

- **DRUG:** Sofosbuvir Oral Product

## Key facts

- **NCT ID:** NCT04169464
- **Lead sponsor:** MTI University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2019-11
- **Final completion:** 2019-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04169464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04169464, "The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04169464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*